For the Inventor, By the Inventor

Enter inventor name

Collegeville, PA, United States of America

William Henry Miller

USPTO Granted Patents = 73 (Patent Applications = 7)

CIPO Patents = 2 (Patent Applications = 10)

EPO Patents = 18 (Patent Applications = 25)

Average Co-Inventor Count = 4.0

ph-index = 17

Forward Citations = 695(Granted Patents)

Forward Citations (Not Self Cited) = 576(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Glen Mills, PA (US) (1995)
Schwenksville, PA (US) (1996 - 2004)
Collegville, PA (US) (2007)
Little Chesterford, GB (2023)
Collegeville, PA (US) (2002 - 2024)

Company Filing History:

19 out of 2,198

Smithkline Beecham Corporation

Glaxosmithkline LLC

Affinium Pharmaceuticals, Inc.

4. 14 out of 1,168

Glaxo Group Limited

Glaxosmithkline Intellectual Property (no.2) Limited

6. 3 out of 206

The Dupont Merck Pharmaceutical Company

7. 2 out of 230

Glaxosmithkline Intellectual Property Development Limited

8. 1 out of 106

Dupont Pharmaceuticals Company

Syndax Pharmaceuticals, Inc.

10. 1 out of 85

Vitae Pharmaceuticals, Inc.

11. 1 out of 262

Cancer Research Technology Limited

where one patent can have more than one assignee

Years Active: 1995-2024

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Menin-MLL Interaction Inhibitors

P13-Kinase Activity Inhibitors

DNMT1 Inhibitors

Sirtuin Modulators

Enhancer Of Zeste Homolog 2 Inhibitors

Cyclopropylamines

Azaindazoles

Indazoles

N-Substituted Glycine Derivatives

FAB I Inhibitors

Antibacterial Agents

Aminopiperidine Derivatives

73 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11919901 - Inhibitors of the menin-MLL interaction (2024-03-05),

2. 11555040 - Oxepinopyrazole derivatives as inhibitors of P13-kinase activity (2023-01-17),

3. 10975056 - Substituted pyridines as inhibitors of DNMT1 (2021-04-13),

4. 10590135 - Substituted bridged urea analogs as sirtuin modulators (2020-03-17),

5. 10072011 - Substituted bridged urea analogs as sirtuin modulators (2018-09-11),

6. 9834558 - Substituted bridged urea analogs as sirtuin modulators (2017-12-05),

7. 9790212 - Enhancer of zeste homolog 2 inhibitors (2017-10-17),

8. 9649307 - Indoles (2017-05-16),

9. 9505745 - Enhancer of zeste homolog 2 inhibitors (2016-11-29),

10. 9402836 - Indoles (2016-08-02),

11. 9382234 - Enhancer of Zeste Homolog 2 inhibitors (2016-07-05),

12. 9346840 - Cyclopropylamines as LSD1 inhibitors (2016-05-24),

13. 9114141 - Indoles (2015-08-25),

14. 9073924 - Azaindazoles (2015-07-07),

15. 9018382 - Indazoles (2015-04-28),

Title: The Legacy of William Henry Miller

Introduction: William Henry Miller, a distinguished inventor hailing from Collegeville, PA, has made significant contributions to the field of innovation with his groundbreaking ideas and inventions.

Latest Patents: William Henry Miller's latest patents include a revolutionary design for a solar-powered water purification system and a cutting-edge technology for sustainable energy storage.

Career Highlights: Throughout his illustrious career, William Henry Miller has been recognized for his innovative spirit and dedication to creating solutions for pressing global challenges. His work in renewable energy and environmental sustainability has garnered praise from experts in the field.

Collaborations: William Henry Miller has collaborated with leading research institutions and universities to further develop his inventions. His partnerships with top scientists and engineers have resulted in the successful implementation of his ideas into real-world applications.

Conclusion: In conclusion, William Henry Miller stands as a beacon of innovation in Collegeville, PA, leaving a lasting impact on the world of inventions and patents. His relentless pursuit of technological advancement continues to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…